Cardio Renal Metabolic

Supporting your cardio renal metabolic (CRM) brand with integrated strategies.

We help you stay ahead in the world of CRM, where comorbid conditions, polypharmacy, and evolving payer framework converge.

Our expertise spans therapy areas including diabetes, chronic kidney disease, and cardiovascular disease. We deliver strategy development, value demonstration, and stakeholder engagement anchored in real-world outcomes and clinical-economic expertise.

From managing co-morbidities to designing adherence and affordability programs, we build access solutions that address full patient journeys. 

In 2025, Precision AQ Supported:

0 +

cardiology products

0 +

renal products 

0 +

metabolic & endocrine products 

GettyImages-1307460113-Woman_Injecting_Herself-RET

Navigating A Shifting Landscape

In CRM, change is constant: new clinical guidelines, evolving quality metrics, and increased scrutiny on cost-effectiveness. We help clients navigate this by aligning product value with payer and provider expectations — translating clinical differentiation into real-world economic impact across chronic, comorbid conditions. 

 

From SGLT inhibitors and GLP-1s, to digital companion programs, our strategies support long-term disease management, drive adherence, and reinforce care coordination across silos. 

gettyimages-1091918678-170667a-1

Grounded In Real-World Insight

Our CRM teams bring a systems-level view. With backgrounds in cardiology, nephrology, endocrinology, and population health, our experts have led brand strategy and value-based care initiatives at the payer and provider level. 

 

We combine this with data analytics and policy insight to make every CRM engagement evidence-based and relevant. We know what it takes to move the needle across integrated care environments.

Discover the New Blueprint for Empowering Access with Precision AQ.